Meridian Bioscience reported $194.98M in Current Assets for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Accelerate Diagnostics AXDX:US 83.7M 1.88M
Antares Pharma ATRS:US $ 127.96M 5.56M
Atrion ATRI:US 125.83M 5.87M
Becton, Dickinson and BDX:US $ 9538M 462M
Bio Rad Laboratories BIO:US $ 2289.09M 113.78M
Cerulean Pharma CERU:US $ 14.06M 4.46M
Cerus CERS:US $ 185.59M 4.32M
Genmark Diagnostics GNMK:US $ 172.96M 2.95M
Luminex LMNX:US $ 481.78M 27.25M
Meridian Bioscience VIVO:US $ 194.98M 6.68M
Myriad Genetics MYGN:US $ 525.1M 195.9M
Neogen NEOG:US $ 609.12M 17.67M
Orasure Technologies OSUR:US $ 285.05M 7.36M
Oxford Immunotec Global OXFD:US $ 188.37M 1.42M
Quidel QDEL:US $ 917.69M 365.03M
Rockwell Medical RMTI:US $ 52.4M 6.84M
Sientra SIEN:US 151.54M 7.63M
Staar Surgical STAA:US $ 248.12M 24.6M
Thermo Fisher Scientific TMO:US $ 19260M 1575M
Trinity Biotech TRIB:US $ 81.46M 6.15M
Utah Medical Products UTMD:US $ 66.62M 9.36M